CN109669032B - 一种固定细胞的方法及细胞固定试剂 - Google Patents
一种固定细胞的方法及细胞固定试剂 Download PDFInfo
- Publication number
- CN109669032B CN109669032B CN201811587708.6A CN201811587708A CN109669032B CN 109669032 B CN109669032 B CN 109669032B CN 201811587708 A CN201811587708 A CN 201811587708A CN 109669032 B CN109669032 B CN 109669032B
- Authority
- CN
- China
- Prior art keywords
- cells
- glyoxal
- fixing
- solution
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 22
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical group O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims abstract description 140
- 229940015043 glyoxal Drugs 0.000 claims abstract description 70
- 210000004027 cell Anatomy 0.000 claims description 97
- 238000004113 cell culture Methods 0.000 claims description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 16
- 241000700605 Viruses Species 0.000 claims description 15
- 239000013078 crystal Substances 0.000 claims description 13
- 239000000834 fixative Substances 0.000 claims description 10
- 229960000583 acetic acid Drugs 0.000 claims description 8
- 238000007865 diluting Methods 0.000 claims description 8
- 239000012362 glacial acetic acid Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004043 dyeing Methods 0.000 claims description 6
- 229920000936 Agarose Polymers 0.000 claims description 4
- 239000011543 agarose gel Substances 0.000 claims description 4
- 239000006143 cell culture medium Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 4
- 239000012498 ultrapure water Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims 2
- 229930040373 Paraformaldehyde Natural products 0.000 abstract description 33
- 229920002866 paraformaldehyde Polymers 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 22
- 239000000243 solution Substances 0.000 description 52
- 239000008055 phosphate buffer solution Substances 0.000 description 7
- 241000282552 Chlorocebus aethiops Species 0.000 description 4
- 241000282324 Felis Species 0.000 description 4
- 206010039491 Sarcoma Diseases 0.000 description 4
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 4
- 208000036142 Viral infection Diseases 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 210000003292 kidney cell Anatomy 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000282560 Macaca mulatta Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000001130 astrocyte Anatomy 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003517 fume Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241001480512 Mammalian orthoreovirus 3 Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000702263 Reovirus sp. Species 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/305—Fixative compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811587708.6A CN109669032B (zh) | 2018-12-25 | 2018-12-25 | 一种固定细胞的方法及细胞固定试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811587708.6A CN109669032B (zh) | 2018-12-25 | 2018-12-25 | 一种固定细胞的方法及细胞固定试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109669032A CN109669032A (zh) | 2019-04-23 |
CN109669032B true CN109669032B (zh) | 2022-01-18 |
Family
ID=66147152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811587708.6A Active CN109669032B (zh) | 2018-12-25 | 2018-12-25 | 一种固定细胞的方法及细胞固定试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109669032B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111020060A (zh) * | 2019-12-19 | 2020-04-17 | 苏州药明检测检验有限责任公司 | 一种利用空斑染色测定异嗜性鼠白血病病毒滴度的方法 |
CN112359141A (zh) * | 2020-11-06 | 2021-02-12 | 苏州药明检测检验有限责任公司 | 一种利用空斑染色测定伪狂犬病毒滴度的方法 |
CN112359140A (zh) * | 2020-11-06 | 2021-02-12 | 苏州药明检测检验有限责任公司 | 一种利用空斑染色测定鼠细小病毒滴度的方法 |
CN112359139A (zh) * | 2020-11-06 | 2021-02-12 | 苏州药明检测检验有限责任公司 | 利用组织半数感染法染色测定异嗜性鼠白血病病毒滴度的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6426196B1 (en) * | 1996-04-05 | 2002-07-30 | Chiron Corporation | Alphavirus structural protein expression cassettes |
CN101311724A (zh) * | 2007-05-24 | 2008-11-26 | 深圳迈瑞生物医疗电子股份有限公司 | 单群白细胞模拟离子、包含单群白细胞模拟离子的校准物及其制备方法 |
CN101311725A (zh) * | 2007-05-25 | 2008-11-26 | 深圳迈瑞生物医疗电子股份有限公司 | 一种五分类白细胞质控物及其制备方法 |
CN101881778A (zh) * | 2009-05-06 | 2010-11-10 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞模拟物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5188935A (en) * | 1984-05-31 | 1993-02-23 | Coulter Electronics, Inc. | Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes |
DE3587636T2 (de) * | 1984-05-31 | 1994-03-10 | Coulter Corp | Reagenssystem und verfahren zum nachweis, aufzählen und prüfen der klassen und unterklassen von blutleukozyten. |
CN101509903B (zh) * | 2009-03-20 | 2012-05-30 | 南京工业大学 | 一种乙二醛、乙醛酸的高效液相色谱分析法 |
CN107043750A (zh) * | 2017-06-13 | 2017-08-15 | 北京焕生汇生物技术研究院 | 一种dc细胞诱导试剂盒及dc细胞诱导培养方法 |
CN108982391A (zh) * | 2018-09-21 | 2018-12-11 | 重庆鹏凯精细化工有限公司 | 羟乙基/羟丙基甲基纤维素中残留乙二醛含量的检测方法 |
-
2018
- 2018-12-25 CN CN201811587708.6A patent/CN109669032B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6426196B1 (en) * | 1996-04-05 | 2002-07-30 | Chiron Corporation | Alphavirus structural protein expression cassettes |
CN101311724A (zh) * | 2007-05-24 | 2008-11-26 | 深圳迈瑞生物医疗电子股份有限公司 | 单群白细胞模拟离子、包含单群白细胞模拟离子的校准物及其制备方法 |
CN101311725A (zh) * | 2007-05-25 | 2008-11-26 | 深圳迈瑞生物医疗电子股份有限公司 | 一种五分类白细胞质控物及其制备方法 |
CN101881778A (zh) * | 2009-05-06 | 2010-11-10 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞模拟物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109669032A (zh) | 2019-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109669032B (zh) | 一种固定细胞的方法及细胞固定试剂 | |
Winkler et al. | Airborne rabies transmission in a laboratory worker | |
Vogel et al. | Adsorption-hemagglutination test for influenza virus in monkey kidney tissue culture | |
Hoorn et al. | On the growth of certain “newer” respiratory viruses in organ cultures | |
EP0891420B1 (en) | Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | |
Moe et al. | Plaque assay for Ebola virus | |
Gohrbandt et al. | H9 avian influenza reassortant with engineered polybasic cleavage site displays a highly pathogenic phenotype in chicken | |
Koyama et al. | The mode of entry of herpes simplex virus type 1 into Vero cells | |
KR20080081275A (ko) | 부유 바이러스 감염 대책 방법 | |
Sela et al. | Identification of the active component of an antiviral factor isolated from virus-infected plants | |
CN105267971A (zh) | 一种不含明胶和人血白蛋白的疫苗冻干保护剂 | |
Vainrub et al. | Latin American hemorrhagic fever | |
Yanamura et al. | Studies on the virus of psittacosis cultivated in vitro | |
Ren et al. | Apoptosis induced by the SARS-associated coronavirus in Vero cells is replication-dependent and involves caspase | |
CN107349220A (zh) | 一种包含成纤维细胞外泌体的制剂及其用途 | |
Simmons et al. | Isolation and identification of a turkey respiratory adenovirus | |
Cai et al. | Characterization of the duck plague virus UL35 gene | |
EP0808361A1 (en) | Novel replication process | |
Lee et al. | Morphologic expression of glandular differentiation in the epidermoid nasal carcinomas induced by phenylglycidyl ether inhalation. | |
Mogabgab et al. | Isolation and cytopathogenic effect of influenza B viruses in monkey kidney cultures. | |
Ginder et al. | Effect of Semliki Forest virus on rabbit fibroma. | |
CN113855782A (zh) | 天麻多肽在制备抗新冠病毒的外用防护产品中的用途 | |
Bećarević et al. | Effect of ultra-violet light on tobacco mosaic virus containing 5-fluorouracil | |
Burke et al. | The isolation of a latent adenolike virus from chicken kidney cell cultures | |
Bayyari et al. | Pathogenicity studies of an Arkansas variant infectious bursal disease virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 215104 No. 1336 Wuzhong Avenue, Wuzhong District, Suzhou City, Jiangsu Province Applicant after: Suzhou Pharmacopoeia Testing and Inspection Co., Ltd. Address before: 215104 No. 1336 Wuzhong Avenue, Wuzhong District, Suzhou City, Jiangsu Province Applicant before: SUZHOU YAOMING KANGDE INSPECTION TESTING CO., LTD. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Lei Jing Inventor after: Qiu Yitao Inventor after: Gao Qing Inventor after: Yang Junrong Inventor after: Liu Haixia Inventor after: Wang Shuo Inventor before: Lei Jing Inventor before: Qiu Yitao Inventor before: Gao Qing Inventor before: Yang Junrong Inventor before: Liu Haixia Inventor before: Wang Shuo |
|
CB03 | Change of inventor or designer information | ||
CP02 | Change in the address of a patent holder |
Address after: 215104 North Side of Wuzhong Avenue, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee after: Suzhou Pharmacopoeia Testing and Inspection Co.,Ltd. Address before: 215104 No. 1336 Wuzhong Avenue, Wuzhong District, Suzhou City, Jiangsu Province Patentee before: Suzhou Pharmacopoeia Testing and Inspection Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |